Impact of rare and common genetic variants on diabetes diagnosis by hemoglobin A1c in multi-ancestry cohorts: The Trans-Omics for Precision Medicine Program.
Laura M Raffield,
Paul S. de Vries,
Jennifer A Brody,
Mark O Goodarzi,
Bertha A. Hidalgo,
Heather M Highland,
Rakhi P Naik,
James A Perry,
Bianca C Porneala,
Bruce M. Psaty,
Joanne E. Curran,
Juan M. Peralta,
Andrew D. Johnson,
Alexander P. Reiner,
Braxton D. Mitchell,
L. Adrienne Cupples,
Ramachandran S. Vasan,
Alanna C. Morrison,
Jerome I. Rotter,
Stephen S Rich,
Alisa K. Manning,
James B. Meigs,
on behalf of the Trans-Omics for Precision Medicine (TOPMed) Diabetes and TOPMed Hematology and Hemostasis working groups and the NHLBI TOPMed Consortium
Posted 28 May 2019
bioRxiv DOI: 10.1101/643932 (published DOI: 10.1016/j.ajhg.2019.08.010)
Posted 28 May 2019
Hemoglobin A1c (HbA1c) is widely used to diagnose diabetes and assess glycemic control in patients with diabetes. However, nonglycemic determinants, including genetic variation, may influence how accurately HbA1c reflects underlying glycemia. Analyzing the NHLBI Trans-Omics for Precision Medicine (TOPMed) sequence data in 10,338 individuals from five studies and four ancestries (6,158 Europeans, 3,123 African-Americans, 650 Hispanics and 407 East Asians), we confirmed five regions associated with HbA1c ( GCK in Europeans and African-Americans, HK1 in Europeans and Hispanics, FN3K / FN3KRP in Europeans and G6PD in African-Americans and Hispanics) and discovered a new African-ancestry specific low-frequency variant (rs1039215 in HBG2 / HBE1 , minor allele frequency (MAF)=0.03). The most associated G6PD variant (p.Val98Met, rs1050828-T, MAF=12% in African-Americans, MAF=2% in Hispanics) lowered HbA1c (-0.88% in hemizygous males, -0.34% in heterozygous females) and explained 23% of HbA1c variance in African-Americans and 4% in Hispanics. Additionally, we identified a rare distinct G6PD coding variant (rs76723693 - p.Leu353Pro, MAF=0.5%; -0.98% in hemizygous males, -0.46% in heterozygous females) and detected significant association with HbA1c when aggregating rare missense variants in G6PD . We observed similar magnitude and direction of effects for rs1039215 ( HBG2 ) and rs76723693 ( G6PD ) in the two largest TOPMed African-American cohorts and replicated the rs76723693 association in the UK Biobank African-ancestry participants. These variants in G6PD and HBG2 were monomorphic in the European and Asian samples. African or Hispanic ancestry individuals carrying G6PD variants may be underdiagnosed for diabetes when screened with HbA1c. Thus, assessment of these variants should be considered for incorporation into precision medicine approaches for diabetes diagnosis.
- Downloaded 309 times
- Download rankings, all-time:
- Site-wide: 49,125 out of 84,910
- In genetics: 2,827 out of 4,455
- Year to date:
- Site-wide: 45,278 out of 84,910
- Since beginning of last month:
- Site-wide: 40,449 out of 84,910
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!